Your browser is no longer supported. Please, upgrade your browser.
Settings
ATRS Antares Pharma, Inc. daily Stock Chart
ATRS [NASD]
Antares Pharma, Inc.
Index- P/E- EPS (ttm)-0.12 Insider Own1.20% Shs Outstand251.47M Perf Week-44.13%
Market Cap526.83M Forward P/E209.50 EPS next Y0.01 Insider Trans-4.13% Shs Float141.72M Perf Month-27.51%
Income-18.20M PEG- EPS next Q-0.03 Inst Own37.00% Short Float4.12% Perf Quarter-34.53%
Sales53.10M P/S9.92 EPS this Y-11.40% Inst Trans0.16% Short Ratio3.45 Perf Half Y-22.98%
Book/sh0.26 P/B8.06 EPS next Y109.10% ROA-25.70% Target Price4.66 Perf Year24.70%
Cash/sh0.17 P/C12.14 EPS next 5Y- ROE-41.40% 52W Range1.41 - 4.09 Perf YTD-10.09%
Dividend- P/FCF- EPS past 5Y-28.30% ROI-53.60% 52W High-48.78% Beta0.37
Dividend %- Quick Ratio3.00 Sales past 5Y26.00% Gross Margin50.00% 52W Low48.58% ATR0.26
Employees110 Current Ratio3.50 Sales Q/Q9.80% Oper. Margin-33.60% RSI (14)26.95 Volatility7.73% 5.12%
OptionableYes Debt/Eq0.61 EPS Q/Q53.50% Profit Margin-34.30% Rel Volume3.61 Prev Close2.32
ShortableYes LT Debt/Eq0.61 EarningsNov 07 BMO Payout- Avg Volume1.69M Price2.10
Recom1.40 SMA20-37.18% SMA50-33.67% SMA200-25.57% Volume6,110,820 Change-9.70%
Jun-23-17Initiated H.C. Wainwright Buy $5
Apr-21-17Initiated Raymond James Strong Buy
May-28-15Initiated Jefferies Buy $5
May-18-15Initiated Piper Jaffray Overweight $3.50
Aug-08-13Reiterated Ladenburg Thalmann Buy $5 → $5.75
Jun-21-13Resumed Oppenheimer Outperform $6
Oct-16-17 08:33AM  Antares Pharma, Inc. breached its 50 day moving average in a Bearish Manner : ATRS-US : October 16, 2017 Capital Cube -9.70%
Oct-13-17 04:00PM  Why Antares Pharma Inc Plummeted Today Motley Fool -37.80%
08:00AM  Today's Research Reports on Trending Tickers: Antares Pharma and Infinity Pharmaceuticals ACCESSWIRE
Oct-12-17 05:16PM  Antares Pharma stock plunges more than 30% after FDA letter MarketWatch -5.33%
05:00PM  Antares Pharma Provides XYOSTED Regulatory Update GlobeNewswire
07:30AM  Corporate News Blog - Antares Pharma Sells ZOMAJET(TM) Assets in a Potential $14.5 Million Deal ACCESSWIRE
Oct-10-17 07:00AM  Antares Pharma Announces Sale of ZOMAJET Needle-Free Delivery System to Ferring Pharmaceuticals GlobeNewswire +5.60%
Oct-09-17 11:18AM  ETFs with exposure to Antares Pharma, Inc. : October 9, 2017 Capital Cube
Oct-05-17 10:23AM  Recent Tech Big-Cap Laggards Finally Gain Some Attention TheStreet.com
Oct-04-17 11:06AM  Biotech Names Flexing Their Muscles TheStreet.com +6.34%
Sep-27-17 08:08AM  Antares Pharma, Inc. breached its 50 day moving average in a Bullish Manner : ATRS-US : September 27, 2017 Capital Cube
Sep-26-17 10:41AM  ETFs with exposure to Antares Pharma, Inc. : September 26, 2017 Capital Cube
Sep-20-17 08:40AM  Antares Pharma to Present at the Ladenburg Thalmann 2017 Healthcare Conference GlobeNewswire
Sep-19-17 06:39PM  Is There Now An Opportunity In Antares Pharma Inc (ATRS)? Simply Wall St.
Sep-12-17 09:00AM  Antares: Positive Phase III Trials May Support the Case for Approval of Xyosted ACCESSWIRE
Sep-11-17 09:11PM  ETFs with exposure to Antares Pharma, Inc. : September 12, 2017 Capital Cube
Sep-08-17 03:54PM  Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 8, 2017 Capital Cube
Sep-05-17 07:00AM  Antares Pharma to Present at the Rodman & Renshaw 19th Annual Global Investment Conference GlobeNewswire
Aug-25-17 08:37AM  Antares Pharma, Inc. breached its 50 day moving average in a Bullish Manner : ATRS-US : August 25, 2017 Capital Cube
Aug-21-17 05:46PM  Antares Pharma, Inc. Value Analysis (NASDAQ:ATRS) : August 21, 2017 Capital Cube
Aug-14-17 01:00PM  ATRS: Milestones Continue to Align for Multiple 2018 Launches Zacks Small Cap Research
Aug-13-17 07:36AM  Edited Transcript of ATRS earnings conference call or presentation 8-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-17 09:39AM  Antares Pharma, Inc. breached its 50 day moving average in a Bearish Manner : ATRS-US : August 10, 2017 Capital Cube
Aug-08-17 10:21PM  Antares Pharma reports 2Q loss Associated Press
07:00AM  Antares Pharma Reports Second Quarter 2017 Operating And Financial Results GlobeNewswire
Aug-01-17 07:00AM  Antares Pharma to Report Second Quarter 2017 Financial and Operating Results and Host Webcast and Conference Call GlobeNewswire
Jul-07-17 02:31PM  ETFs with exposure to Antares Pharma, Inc. : July 7, 2017 Capital Cube
Jun-26-17 03:21PM  ETFs with exposure to Antares Pharma, Inc. : June 26, 2017 Capital Cube
08:00AM  Today's Research Reports on Stocks to Watch: Juno Therapeutics and Antares Pharma Accesswire
08:00AM  AMAG Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for Makena® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector GlobeNewswire
Jun-15-17 01:08PM  ETFs with exposure to Antares Pharma, Inc. : June 15, 2017 Capital Cube
Jun-14-17 09:53AM  Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-13-17 01:17PM  Antares Pharma, Inc. Value Analysis (NASDAQ:ATRS) : June 13, 2017 Capital Cube +6.83%
Jun-12-17 08:56AM  Antares Pharma, Inc. breached its 50 day moving average in a Bullish Manner : ATRS-US : June 12, 2017 Capital Cube
Jun-08-17 10:25AM  Edited Transcript of ATRS earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents
Jun-07-17 07:00AM  Antares Pharma Announces Debt Financing From Hercules Capital GlobeNewswire
Jun-01-17 07:00AM  Antares Pharma to Present at the Jefferies 2017 Healthcare Conference GlobeNewswire
May-16-17 07:00AM  Antares Pharma Announces Poster Presentation at the American Urological Association Annual Meeting GlobeNewswire
May-09-17 07:55PM  Edited Transcript of ATRS earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents
09:01AM  Antares Pharma reports 1Q loss Associated Press
07:00AM  Antares Pharma Reports First Quarter 2017 Operating and Financial Results GlobeNewswire
May-02-17 07:00AM  Antares Pharma to Report First Quarter 2017 Financial and Operating Results and Host Webcast and Conference Call GlobeNewswire
Apr-27-17 07:00AM  Antares Pharma to Present at the Deutsche Bank Securities, Inc. 42nd Annual Health Care Conference GlobeNewswire
Apr-26-17 10:57AM  Don't Be Surprised If Dip Buyers Jump In on Any Pullback TheStreet.com
Apr-25-17 03:22PM  ETFs with exposure to Antares Pharma, Inc. : April 25, 2017 Capital Cube +8.90%
Apr-17-17 08:00AM  AMAG Submits Supplemental New Drug Application to FDA for Makena® (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use GlobeNewswire
Apr-07-17 03:53PM  ETFs with exposure to Antares Pharma, Inc. : April 7, 2017 Capital Cube
Apr-03-17 07:00AM  Antares Pharma Announces Poster Presentation of Quickshot Testosterone Data at the Endocrine Society Annual Meeting GlobeNewswire
Mar-31-17 12:00PM  Penny Stocks to Watch for April 2017 (ATRS, WRN) Investopedia
12:00PM  Penny Stocks to Watch for April 2017 (ATRS, WRN) at Investopedia
Mar-27-17 03:49PM  ETFs with exposure to Antares Pharma, Inc. : March 27, 2017 Capital Cube
03:49PM  ETFs with exposure to Antares Pharma, Inc. : March 27, 2017
Mar-21-17 10:00AM  ATRS: 2016 Financial and Operational Results Zacks Small Cap Research -6.03%
Mar-20-17 11:43AM  Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
11:43AM  Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Mar-18-17 01:04PM  ANTARES PHARMA, INC. Financials
Mar-16-17 09:48AM  Antares Pharma, Inc. :ATRS-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017 Capital Cube
09:48AM  Antares Pharma, Inc. :ATRS-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017
Mar-15-17 09:30AM  Antares Pharma Inc. and Nivalis Therapeutics Inc. Show Resiliency as They Snap Back from Late 2016 Uncertainties Accesswire +6.18%
Mar-14-17 07:12AM  Antares Pharma reports 4Q loss Associated Press
07:07AM  Q4 2016 Antares Pharma Inc Earnings Release - Before Market Open
07:01AM  ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
07:00AM  Antares Pharma Reports Fourth Quarter and Full Year 2016 Operating and Financial Results GlobeNewswire
Mar-06-17 08:30AM  Antares Pharma to Report Fourth Quarter and Full Year 2016 Financial and Operating Results and Host Webcast and Conference Call GlobeNewswire
08:11AM  ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fin
Feb-28-17 07:00AM  Antares Pharma to Present at the Cowen and Company 37th Annual Healthcare Conference GlobeNewswire
Feb-27-17 07:00AM  Antares Pharma Announces FDA Acceptance of New Drug Application for Quickshot® Testosterone GlobeNewswire
Feb-03-17 08:06AM  AMAG Down Despite Positive Data on Makena Auto-Injector
Jan-31-17 09:30AM  Biotech Acquisitions on the Rise in 2017: Latest Reports on Antares Pharma and ACADIA Pharmaceuticals Accesswire
Jan-27-17 04:39PM  ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-24-17 10:06AM  Antares Pharma, Inc. Value Analysis (NASDAQ:ATRS) : January 24, 2017
Jan-23-17 07:37AM  Antares Pharma, Inc. breached its 50 day moving average in a Bullish Manner : ATRS-US : January 23, 2017
Jan-20-17 12:52PM  ETFs with exposure to Antares Pharma, Inc. : January 20, 2017
Jan-03-17 12:33PM  ETFs with exposure to Antares Pharma, Inc. : January 3, 2017
Dec-21-16 08:00AM  Antares Pharma Announces Submission of New Drug Application for Quickshot® Testosterone GlobeNewswire
Dec-19-16 11:26AM  ETFs with exposure to Antares Pharma, Inc. : December 19, 2016
07:00AM  Antares Pharma Announces the Successful Completion of Tevas Decentralized Procedure for Teriparatide Injection in Europe GlobeNewswire
Dec-16-16 08:15AM  Post Earnings Coverage as Cooper Cos Revenue Climbed 14%; Non-GAAP EPS Also Added 14% Accesswire
Dec-13-16 04:11PM  Weekly CFO Buys Highlights
Dec-09-16 06:33AM  Here is What Hedge Funds Think About Antares Pharma Inc (ATRS) at Insider Monkey
Dec-08-16 12:14PM  ETFs with exposure to Antares Pharma, Inc. : December 8, 2016
Nov-28-16 11:54AM  ETFs with exposure to Antares Pharma, Inc. : November 28, 2016
Nov-23-16 10:01AM  Antares Pharma, Inc. :ATRS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 23, 2016
07:00AM  Antares Pharma to Present at the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-10-16 07:00AM  Antares Pharma to Present at the Jefferies 2016 Global Healthcare Conference GlobeNewswire
Nov-09-16 08:09AM  Antares Pharma reports 3Q loss +7.19%
08:02AM  ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
07:07AM  Q3 2016 Antares Pharma Inc Earnings Release - Before Market Open
07:00AM  Antares Pharma Reports Third Quarter 2016 Financial and Operating Results GlobeNewswire
Nov-03-16 07:00AM  Antares Pharma to Report Third Quarter Financial and Operating Results and Host Webcast and Conference Call GlobeNewswire -7.41%
Nov-02-16 07:00AM  Antares Pharma Announces Presentations at the Sexual Medicine Society Scientific Annual Meeting GlobeNewswire
Nov-01-16 05:24PM  ANTARES PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financi
Oct-31-16 09:00AM  Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer GlobeNewswire
Oct-28-16 07:00AM  Antares Pharma Announces Multiple Presentations at the Sexual Medicine Society Scientific Annual Meeting GlobeNewswire
Oct-04-16 09:40AM  ETFs with exposure to Antares Pharma, Inc. : October 4, 2016 -5.68%
Sep-27-16 04:02PM  ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
11:00AM  Will Antares Pharma (ATRS) Continue to Surge Higher?
Sep-22-16 07:00AM  Antares Pharma Announces Completion of the QuickShot Testosterone Clinical Program GlobeNewswire
Sep-20-16 07:00AM  Antares Pharma to Present at the Ladenburg Thalmann 2016 Healthcare Conference GlobeNewswire
Sep-14-16 04:57PM  ANTARES PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Antares Pharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache; ZOMA-Jet and Twin-Jector, a needle-free auto injector to deliver human growth hormone treatment to children without the use of a needle; and VIBEX disposable pressure-assisted auto injectors. In addition, the company is developing VIBEX auto injectors for treating anaphylaxis; disposable pen injectors for diabetes and osteoporosis; Makena QuickShot auto injectors for reducing risk of preterm birth; and VIBEX QS Testosterone for testosterone replacement therapy for men who have testosterone deficiency. It has strategic alliances and partnership arrangements with Teva Pharmaceutical Industries, Ltd.; AMAG Pharmaceuticals, Inc.; Ferring Pharmaceuticals Inc.; and Ferring B.V. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
APPLE ROBERT FPresident & CEODec 27Option Exercise1.2360,00073,800929,719Dec 29 05:33 PM
JACOB LEONARD SDirectorOct 09Option Exercise0.55218,600119,800407,485Oct 11 05:56 PM
JACOB LEONARD SDirectorOct 09Sale4.05230,000931,920207,485Oct 11 05:56 PM
GARRITY THOMAS JDirectorOct 03Option Exercise0.8530,00025,500190,213Oct 05 05:57 PM
GARRITY THOMAS JDirectorOct 03Sale3.5030,000105,000160,213Oct 05 05:57 PM
Powell Fred MSenior Vice President & CFOJun 09Buy2.79130,000363,272331,434Jun 13 08:02 AM
APPLE ROBERT FPresident & CEOApr 05Option Exercise1.653,0004,950893,002Apr 05 05:26 PM
APPLE ROBERT FPresident & CEOApr 05Sale3.003,0009,000890,002Apr 05 05:26 PM
JACOB LEONARD SDirectorApr 04Option Exercise1.6521,76235,907240,647Apr 05 05:23 PM
APPLE ROBERT FPresident & CEOApr 04Option Exercise1.6537,00061,050927,002Apr 05 05:26 PM
APPLE ROBERT FPresident & CEOApr 04Sale3.0037,000111,070890,002Apr 05 05:26 PM
JACOB LEONARD SDirectorApr 04Sale2.9021,76263,112218,885Apr 05 05:23 PM
JACOB LEONARD SDirectorApr 03Option Exercise1.6520,00033,000238,885Apr 05 05:23 PM
JACOB LEONARD SDirectorApr 03Sale2.8820,00057,570218,885Apr 05 05:23 PM
GARRITY THOMAS JDirectorMar 31Option Exercise1.6530,00049,500190,213Apr 04 05:37 PM
GONELLA JACQUESDirectorMar 31Option Exercise1.6530,00049,50012,056,413Apr 04 05:41 PM
GARRITY THOMAS JDirectorMar 31Sale2.9130,00087,276160,213Apr 04 05:37 PM
Powell Fred MSenior Vice President & CFODec 09Buy2.03100,000202,500100,000Dec 12 04:28 PM
JACOB LEONARD SDirectorDec 01Option Exercise1.2320,00024,600238,885Dec 05 05:26 PM
JACOB LEONARD SDirectorDec 01Sale1.9720,00039,416218,885Dec 05 05:26 PM